BME Kenan Distinguished Professor Paul Dayton has been named Interim Chair of the Joint Department of Biomedical Engineering, effective Nov. 1. Dr. Dayton is taking over for Dr. Nancy Allbritton, who has been an outstanding Chair of the BME Department since 2009. Professor Dayton has been part of UNC since 2007, when he was hired as an Associate Professor, and he was serving as the Associate Chair of the Department since 2012.
A member of the UNC Lineberger Comprehensive Cancer Center, Dr. Dayton is an internationally recognized world leader in biomedical ultrasound imaging, ultrasound-targeted therapeutic drug delivery, and using ultrasound imaging to assess tissue perfusion and response to therapy. He is also an expert in translational science, as evidenced by his multiple patents, two clinical trials, and his co-founding of three startup companies: SonoVol, Inc , Nanosonic Bioreagents, LLC, and Triangle Biotechnology, Inc.
Dr. Dayton currently serves as the Associate Director for Education for the UNC Biomedical Research Imaging Center, and is Co-Director for the Certificate Program in Biomedical Imaging Science. Throughout his academic career, Dr. Dayton has demonstrated exceptional scholarship and leadership, and we are excited that he is serving as the Interim Chair of the Department. For the full announcement, you can visit Healthcare News here.
